Skip to content

Clinical trials

Phase 2 Carcinoma, Hepatocellular trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Country / region: Singapore Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20091
20101
20112
20121
20131
20151
20161
20191
20212
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Recruiting3
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Centre, Singapore6
Bayer3
Bristol-Myers Squibb2
Astellas Pharma Inc1
Coherus Oncology, Inc.1
Hoffmann-La Roche1
MedImmune LLC1
Mina Alpha Limited1
National University Hospital, Singapore1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular19
Liver Neoplasms6
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Esophageal Neoplasms1
Hepatitis B1
Hepatitis C1
Squamous Cell Carcinoma of Head and Neck1
Stomach Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.